Medicare Enrolled
Dr. Gregory Breen, M.D.
Critical Care Medicine · Woodbury, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Breen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Breen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Breen
Dr. Gregory Breen is a critical care medicine specialist in Woodbury, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Breen performed 14,123 Medicare services across 2,775 unique beneficiaries.
Between the years covered by Open Payments, Dr. Breen received a total of $5,309 from 36 pharmaceutical and/or device companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Breen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NJ
$5,309 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,123
Medicare services
Top 1% in NJ for critical care medicine
2,775
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~706 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, mepolizumab, 1 mg | 10,500 | $23 | $59 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
757 | $103 | $281 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
333 | $67 | $151 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
268 | $101 | $218 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
240 | $23 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
174 | $12 | $49 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
170 | $145 | $421 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
149 | $103 | $281 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
148 | $44 | $135 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
138 | $68 | $199 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
130 | $44 | $384 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
93 | $283 | $529 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
92 | $46 | $125 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
92 | $151 | $395 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
91 | $33 | $57 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
79 | $8 | $129 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $141 | $365 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
79 | $65 | $199 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
67 | $98 | $1,399 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
52 | $34 | $100 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
50 | $104 | $1,460 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
49 | $32 | $67 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
48 | $181 | $607 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
46 | $70 | $147 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
36 | $1 | $25 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
33 | $16 | $44 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $109 | $287 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
31 | $119 | $314 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
24 | $42 | $82 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $84 | $246 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
13 | $17 | $42 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
11 | $30 | $62 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,309
Total received (2018-2024)
Avg $758/year across 7 years
Top 22% in NJ for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
403
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,309 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$475
2023
$340
2022
$36
2021
$62
2020
$619
2019
$2,111
2018
$1,666
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$168
Philips North America LLC
$116
GENZYME CORPORATION
$52
Grifols USA, LLC
$43
AstraZeneca Pharmaceuticals LP
$33
Actelion Pharmaceuticals US, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
Insmed, Inc.
$15
Harmony Biosciences Llc
$15
Top 3 companies account for 71.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,171
AstraZeneca Pharmaceuticals LP
$806
Boehringer Ingelheim Pharmaceuticals, Inc.
$411
Genentech USA, Inc.
$348
Grifols USA, LLC
$277
Mylan Specialty L.P.
$182
Novartis Pharmaceuticals Corporation
$170
GENZYME CORPORATION
$164
JAZZ PHARMACEUTICALS INC.
$160
Philips Electronics North America Corporation
$152
Actelion Pharmaceuticals US, Inc.
$150
Sunovion Pharmaceuticals Inc.
$140
Philips North America LLC
$116
PFIZER INC.
$116
Electromed, Inc.
$115
Regeneron Healthcare Solutions, Inc.
$94
Insmed, Inc.
$85
Circassia Pharmaceuticals Inc
$80
Jazz Pharmaceuticals Inc.
$69
United Therapeutics Corporation
$57
Janssen Pharmaceuticals, Inc
$52
Vapotherm Inc
$48
Inspire Medical Systems, Inc.
$44
SANOFI PASTEUR INC.
$41
Gilead Sciences, Inc.
$38
Resmed Corp
$34
Harmony Biosciences LLC
$31
Bayer HealthCare Pharmaceuticals Inc.
$29
Teva Pharmaceuticals USA, Inc.
$25
Boston Scientific Corporation
$20
Aytu BioScience, Inc
$16
Harmony Biosciences Llc
$15
Nabriva Therapeutics, plc
$15
Azurity Pharmaceuticals, Inc.
$14
Merck Sharp & Dohme Corporation
$13
ADVANCED RESPIRATORY, INC
$11
Top 3 companies account for 45.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Extended Holter · (8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Adempas · Arikayce · Astral · BREO · BROVANA · CHANTIX · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · Dymista · ELIQUIS · EXALT Model D · Esbriet · FASENRA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · Horizant · INSPIRE · JARDIANCE · LONHALA MAGNAIR · NIOX VERO · NUCALA · Natesto · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Utibron · VAPOTHERM · WAKIX · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xenleta · Xolair · Xyrem · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
126
Per 100K population
41.4
County median income
$102,807
Nearest hospital
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Breen is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Breen experienced with injection, mepolizumab, 1 mg?
Based on Medicare claims data, Dr. Breen performed 10,500 injection, mepolizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Breen receive payments from pharmaceutical companies?
Yes. Dr. Breen received a total of $5,309 from 36 companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Breen's costs compare to other critical care medicines in Woodbury?
Dr. Breen's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Breen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Woodbury
Browse critical care medicines in Woodbury ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in NJ
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in NJ
Which NJ critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology